Suppr超能文献

蛋白激酶的生物化学和药物发现。

Protein kinase biochemistry and drug discovery.

机构信息

Pfizer Worldwide Research and Development, La Jolla, Pfizer Inc., San Diego, CA 92121, United States.

出版信息

Bioorg Chem. 2011 Dec;39(5-6):192-210. doi: 10.1016/j.bioorg.2011.07.004. Epub 2011 Aug 3.

Abstract

Protein kinases are fascinating biological catalysts with a rapidly expanding knowledge base, a growing appreciation in cell regulatory control, and an ascendant role in successful therapeutic intervention. To better understand protein kinases, the molecular underpinnings of phosphoryl group transfer, protein phosphorylation, and inhibitor interactions are examined. This analysis begins with a survey of phosphate group and phosphoprotein properties which provide context to the evolutionary selection of phosphorylation as a central mechanism for biological regulation of most cellular processes. Next, the kinetic and catalytic mechanisms of protein kinases are examined with respect to model aqueous systems to define the elements of catalysis. A brief structural biology overview further delves into the molecular basis of catalysis and regulation of catalytic activity. Concomitant with a prominent role in normal physiology, protein kinases have important roles in the disease state. To facilitate effective kinase drug discovery, classic and emerging approaches for characterizing kinase inhibitors are evaluated including biochemical assay design, inhibitor mechanism of action analysis, and proper kinetic treatment of irreversible inhibitors. As the resulting protein kinase inhibitors can modulate intended and unintended targets, profiling methods are discussed which can illuminate a more complete range of an inhibitor's biological activities to enable more meaningful cellular studies and more effective clinical studies. Taken as a whole, a wealth of protein kinase biochemistry knowledge is available, yet it is clear that a substantial extent of our understanding in this field remains to be discovered which should yield many new opportunities for therapeutic intervention.

摘要

蛋白激酶是一类引人入胜的生物催化剂,其相关知识库不断扩展,在细胞调控中的作用日益受到重视,并在成功的治疗干预中发挥着主导作用。为了更好地理解蛋白激酶,我们对磷酸基团转移、蛋白磷酸化和抑制剂相互作用的分子基础进行了研究。这一分析首先考察了磷酸基团和磷酸化蛋白的特性,为磷酸化作为大多数细胞过程生物调控的核心机制的进化选择提供了背景。接下来,我们研究了蛋白激酶的动力学和催化机制,涉及到模型水相体系,以确定催化的要素。简要的结构生物学概述进一步深入探讨了催化和催化活性调控的分子基础。蛋白激酶在正常生理中起着重要作用,在疾病状态下也具有重要作用。为了促进有效的激酶药物发现,我们评估了用于表征激酶抑制剂的经典和新兴方法,包括生化测定设计、抑制剂作用机制分析以及对不可逆抑制剂的适当动力学处理。由于所得的蛋白激酶抑制剂可以调节预期和非预期的靶标,因此我们还讨论了分析方法,这些方法可以阐明抑制剂更全面的生物学活性,从而可以进行更有意义的细胞研究和更有效的临床研究。总的来说,我们已经掌握了丰富的蛋白激酶生物化学知识,但很明显,我们在这一领域的理解还有很大的一部分有待发现,这应该会为治疗干预带来许多新的机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验